130 related articles for article (PubMed ID: 35263886)
1. Exosomal PTEN as a Predictive Marker of Aggressive Gliomas.
Patnam S; Samal R; Koyyada R; Joshi P; Singh AD; Nagalla B; Soma MR; Sannareddy RR; Ippili K; Raju S; Boola RG; Lath R; Ranjan A; Ghosh S; Balamurugan M; Ray A; Manda SV
Neurol India; 2022; 70(1):215-222. PubMed ID: 35263886
[TBL] [Abstract][Full Text] [Related]
2. Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma.
Chen P; Zhao D; Li J; Liang X; Li J; Chang A; Henry VK; Lan Z; Spring DJ; Rao G; Wang YA; DePinho RA
Cancer Cell; 2019 Jun; 35(6):868-884.e6. PubMed ID: 31185211
[TBL] [Abstract][Full Text] [Related]
3. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
Manda SV; Kataria Y; Tatireddy BR; Ramakrishnan B; Ratnam BG; Lath R; Ranjan A; Ray A
J Neurosurg; 2018 Apr; 128(4):1091-1101. PubMed ID: 28574310
[TBL] [Abstract][Full Text] [Related]
4. Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas.
Sabha N; Knobbe CB; Maganti M; Al Omar S; Bernstein M; Cairns R; Çako B; von Deimling A; Capper D; Mak TW; Kiehl TR; Carvalho P; Garrett E; Perry A; Zadeh G; Guha A; Sidney Croul
Neuro Oncol; 2014 Jul; 16(7):914-23. PubMed ID: 24470545
[TBL] [Abstract][Full Text] [Related]
5. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
6. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analysis of phosphatase and tensin homolog and p16 tumor suppressor genes in patients with malignant glioma.
Abdullah JM; Zainuddin N; Sulong S; Jaafar H; Isa MN
Neurosurg Focus; 2003 Apr; 14(4):e6. PubMed ID: 15679305
[TBL] [Abstract][Full Text] [Related]
8. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
[TBL] [Abstract][Full Text] [Related]
9. Mutations of PTEN gene in gliomas correlate to tumor differentiation and short-term survival rate.
Yang Y; Shao N; Luo G; Li L; Zheng L; Nilsson-Ehle P; Xu N
Anticancer Res; 2010 Mar; 30(3):981-5. PubMed ID: 20393024
[TBL] [Abstract][Full Text] [Related]
10. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
Fujimoto K; Arita H; Satomi K; Yamasaki K; Matsushita Y; Nakamura T; Miyakita Y; Umehara T; Kobayashi K; Tamura K; Tanaka S; Higuchi F; Okita Y; Kanemura Y; Fukai J; Sakamoto D; Uda T; Machida R; Kuchiba A; Maehara T; Nagane M; Nishikawa R; Suzuki H; Shibuya M; Komori T; Narita Y; Ichimura K
Acta Neuropathol; 2021 Aug; 142(2):323-338. PubMed ID: 34148105
[TBL] [Abstract][Full Text] [Related]
11. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
12. Is exon 5 of the PTEN/MMAC1 gene a prognostic marker in anaplastic glioma?
Rustia A; Wierzbicki V; Marrocco L; Tossini A; Zamponi C; Lista F
Neurosurg Rev; 2001 Jul; 24(2-3):97-102. PubMed ID: 11485247
[TBL] [Abstract][Full Text] [Related]
13. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
[TBL] [Abstract][Full Text] [Related]
14. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
15. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
[TBL] [Abstract][Full Text] [Related]
16. Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis.
Xiao WZ; Han DH; Wang F; Wang YQ; Zhu YH; Wu YF; Liu NT; Sun JY
Tumour Biol; 2014 Jul; 35(7):6687-93. PubMed ID: 24705863
[TBL] [Abstract][Full Text] [Related]
17. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
18. Letter regarding Xiao WZ et al. entitled "Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis".
Dai W; Chen J; Guo X; Su Z
Tumour Biol; 2015 Jun; 36(6):4089. PubMed ID: 26025112
[TBL] [Abstract][Full Text] [Related]
19. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
20. Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia.
Abdullah JM; Farizan A; Asmarina K; Zainuddin N; Ghazali MM; Jaafar H; Isa MN; Naing NN
Asian J Surg; 2006 Oct; 29(4):274-82. PubMed ID: 17098662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
